Dry mouth (xerostomia) is a frequent and often disruptive side effect of cancer treatment. When saliva drops, daily activities like speaking, chewing, swallowing and tasting become harder. This article explains why chemotherapy, radiation and many supportive medications can cause dry mouth, what symptoms and complications to watch for, and practical, evidence-based ways to restore lubrication and protect the lining of the mouth. You’ll learn how topical, lipid-based sprays differ from saliva-stimulating medicines and water-based substitutes, how a protective lipid film supports the health of the mouth, and how to use a spray during cancer care. Throughout, we compare topical and systemic options (including pilocarpine and cevimeline) and highlight oral-care measures that lower the risk of tooth decay and infection during and after cancer therapy.
What causes dry mouth during cancer treatment?
Dry mouth during cancer therapy results from reduced salivary function caused by direct gland injury, the effects of chemotherapy, and medication side effects that together reduce lubrication and weaken the mouth’s defences. Radiation to the head and neck can directly damage salivary tissue and ducts; chemotherapy can change saliva composition and irritate the lining of the mouth; and many other drugs taken at the same time (pain relievers, antihistamines, antidepressants) have anticholinergic effects that worsen xerostomia. These processes lead to less saliva, thicker secretions and poorer clearing of the mouth, all of which raise the risk of tooth decay and tissue damage.
Cancer therapies and medications commonly cause dry mouth through three main mechanisms:
- Direct radiation damage to salivary glands in the treated area, reducing their ability to secrete.
- Effects of chemotherapy that alter saliva makeup and the resilience of the mouth lining.
- Medication-related anticholinergic effects, or taking many medicines at once, which blunt salivary reflexes.
Because these pathways differ, tailored approaches, focusing on lubrication, moisture retention or stimulated flow, are needed to relieve symptoms and protect oral health.
How do chemotherapy and radiation lead to xerostomia?
Radiation causes cumulative structural injury to the saliva-producing cells and ducts in the treated area, often producing long-lasting low saliva. Many chemotherapies cause temporary gland dysfunction and inflammation of the mouth lining. Head and neck radiation has the highest rate of persistent dry mouth because the salivary glands are directly exposed; combining treatments increases both severity and duration. In many people, reduced saliva begins during therapy and can persist afterwards, so both immediate symptom control and long-term oral care planning matter.
Studies show that managing cancer therapy-related xerostomia can include a range of tactics, from topical lubricants to other preventive measures.
Cancer therapy-induced xerostomia: management and prevention strategies. Evidence indicates salivary gland hypofunction and therapy-related xerostomia can sometimes be prevented or their symptoms reduced, depending on the cancer treatment. Clinical guidance covers options such as IMRT, amifostine, muscarinic agonist stimulation, oral lubricants, acupuncture and submandibular gland transfer.
What are the symptoms and risks of cancer-related dry mouth?
Common symptoms include ongoing dryness, trouble chewing or swallowing, changes in taste, extra effort when speaking, and a sticky or thick saliva sensation. People often experience poor sleep, discomfort with dentures and reduced appetite because food tastes different or is harder to swallow. Dry mouth increases the risk of tooth decay, oral infections (for example, candida) and oral mucositis, problems that can interfere with nutrition and with completing treatment. Telling your oncology and dental teams early helps you get targeted care.
- Higher risk of tooth decay because of lost salivary buffering and reduced remineralisation.
- Increased chance of oral infections and ulcers.
- Nutrition problems from pain and difficulty swallowing.
These risks make protective lubrication and coordinated oral care essential during cancer therapy.
Radiation-induced xerostomia in head and neck cancer patients: pathogenesis and management. Reviews of the pathogenesis and clinical impact of radiation-induced xerostomia describe its consequences for quality of life and outline preventive and interventional therapies used in practice.
How does Aquoral provide relief during cancer treatment?
Aquoral is a lipid-based oral spray, available without a prescription in Canada, that uses oxidized glycerol triesters (OGT) to form a thin protective lipid film on the lining of the mouth. That film improves lubrication and helps retain moisture, reducing friction and making swallowing and speaking easier. Unlike saliva-stimulating medicines, Aquoral acts locally as a barrier that traps moisture instead of stimulating saliva throughout the body. This means focused relief that can last several hours per application, without the body-wide side effects of oral cholinergic medications. Aquoral is made in France.
- Aquoral (lipid-based OGT): forms a protective lipid film that traps moisture and restores the suppleness of the mouth lining. Relief is commonly reported around 4 to 6 hours after use; it acts locally.
- Pilocarpine and cevimeline (saliva-stimulating medicines): stimulate cholinergic receptors to raise saliva flow throughout the body. They can increase saliva but may cause body-wide side effects; dosing varies.
- Water-based saliva substitutes: provide immediate moisture through water-based lubricants. Relief is shorter-lived, often requiring reapplication every 1 to 2 hours, with no lipid barrier.
This comparison shows why a lipid-film approach can offer longer-lasting relief than water-based options and may be better tolerated than some systemic medicines.
- Targeted lubrication that eases swallowing, speech and oral comfort with fewer body-wide effects.
- A protective barrier that can reduce mechanical irritation of inflamed tissue.
- Easy spray delivery for use around meals and treatments.
These features make Aquoral a useful addition to the other supportive measures your care team recommends.
What is the lipid-based technology behind Aquoral?
Oxidized glycerol triesters (OGT) form a thin, supple lipid film on the lining of the mouth when sprayed. This film mimics natural lipids in the mouth, slows evaporation and restores lubrication. Its structure helps hold water at the surface and reduces friction during speaking and eating, directly addressing the problems caused by xerostomia. Unlike water-based substitutes that evaporate quickly, the OGT lipid film provides sustained moisture retention and less frequent reapplication.
How long does Aquoral’s relief last compared with other treatments?
Aquoral’s topical film typically provides several hours of relief, commonly reported as about four to six hours, which usually means fewer daily applications than water-based sprays. Water-based substitutes often need reapplying every one to two hours, while systemic medicines such as pilocarpine or cevimeline stimulate saliva but can be limited by side effects and by health conditions that rule them out. People on multiple medications or with heart concerns may prefer topical options to reduce exposure to the rest of the body.
Although this guide focuses on cancer-related xerostomia, people with other conditions such as Sjögren’s disease face similar decisions and may also benefit from targeted dry mouth relief.
How can Aquoral help protect against oral mucositis during cancer therapy?
Oral mucositis, painful inflammation and ulcers of the mouth lining, commonly occurs with chemotherapy and radiation, especially in head and neck cancer. Preventing it matters because severe cases can limit nutrition, increase infection risk and force breaks in treatment. By delivering sustained lubrication and a protective barrier, a lipid-based spray like Aquoral can reduce mechanical trauma from eating and speaking and help keep the lining of the mouth more resilient. Sprays don’t guarantee prevention, but they can lower severity and improve daily comfort when used alongside oral hygiene, pain relief and the mucositis plan from your oncology team.
- Lubrication: less friction and irritation, so swallowing is easier and eating less painful.
- Moisture retention: better hydration and barrier function, lowering the risk of cracks and secondary infections.
- Local film formation: physical protection of ulcer-prone areas, with a potential reduction in mucositis severity and better day-to-day comfort.
What is oral mucositis, and why does prevention matter?
Oral mucositis is a common side effect of chemotherapy and radiation, marked by redness, painful ulcers and breakdown of the lining of the mouth, particularly with head and neck treatments. It can lead to severe pain, weight loss from poor intake, secondary infections and interruptions to cancer therapy. Prevention and early management reduce the need for strong pain medicines, help preserve nutrition and support staying on your treatment schedule.
Oral mucositis in cancer patients: prevention and management update. Oral mucositis (OM) is one of the most frequent adverse effects of chemotherapy and radiotherapy in head-and-neck cancer. Managing OM relies on validated assessment tools, supportive care, symptom relief and patient education. Left unmanaged, OM can cause ulcers, severe pain and swallowing problems that may lead to malnutrition and treatment interruptions.
How does Aquoral support the lining of the mouth?
Aquoral delivers a lipid film that adheres to the surfaces of the mouth to support hydration, reduce stress during chewing and speaking, and slow rapid moisture loss. These local effects help with everyday tasks, like swallowing soft foods and talking, and reduce the small injuries that can lead to ulcers. Used with professional dental care, gentle oral hygiene and your oncology team’s mucositis plan, a topical lipid spray is a practical part of protecting your mouth.
Getting and using Aquoral during cancer treatment
In Canada, you can buy Aquoral without a prescription. Before starting, tell your oncology and dental teams about persistent dry mouth and how it affects daily life, so they can check your mouth, review your medicines and fit Aquoral into a complete oral-care plan.
Best practices for using Aquoral during cancer treatment
Use the spray as directed on the package: apply it to the dry areas of your mouth when symptoms appear or before meals, and keep up gentle oral hygiene and good hydration. Spread the product around the mouth with your tongue or a finger so it adheres well. Avoid vigorous rinsing immediately after application so the lipid film can form, and reapply when symptoms return, within the directions on the package. Tell your oncology or dental team quickly about any signs of allergy or unexpected irritation, and build spray use into a daily routine that includes soft foods when needed and regular mouth checks.
- Apply before meals and when swallowing is difficult.
- Time spray use with oral care so you don’t immediately remove the protective film.
- Watch for irritation and tell your care team about any changes.
This article is general information and does not replace advice from your health professional. Content adapted for Canada; pending review.